Experimental analysis showed differences in R1 dispersion in brain tissue of patients with cerebral small vessel disease, indicating potential for new biomarkers.
Motivation: Field-Cycling Imaging accesses new biomarkers of pathology by mapping the dispersion of spin-lattice R1 with magnetic field strength below 0.2 T. Goal(s): To examine the efficacy of Field-Cycling Imaging to interrogate field-dependence of R1 in brain changes arising from cerebral small vessel disease. Approach: Twenty participants were recruited with moderate or severe small vessel disease and underwent 3T MRI and FCI scans, repeated 30 days apart. Results: Differences in R1 dispersion could repeatably be discerned between normal and abnormal appearing brain tissue regions using Field-Cycling Imaging. Impact: This work is a first step towards investigating whether quantitative measurements of low-field R1 dispersion have utility for assessing progression of cerebral small vessel disease.
No takes yet. Share an insight, caveat, or question.
Senn et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: